Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C8G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIGT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6773 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALSU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC254896 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SURF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105369507 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXC12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDLRAD4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHDC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EED - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996667 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on